Annual D&A
$5.64 M
-$884.00 K-13.54%
31 December 2023
Summary:
Adverum Biotechnologies annual depreciation & amortization is currently $5.64 million, with the most recent change of -$884.00 thousand (-13.54%) on 31 December 2023. During the last 3 years, it has risen by +$1.49 million (+35.74%). ADVM annual D&A is now -13.54% below its all-time high of $6.53 million, reached on 31 December 2022.ADVM Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$890.00 K
-$66.00 K-6.90%
30 September 2024
Summary:
Adverum Biotechnologies quarterly depreciation & amortization is currently $890.00 thousand, with the most recent change of -$66.00 thousand (-6.90%) on 30 September 2024. Over the past year, it has dropped by -$619.00 thousand (-41.02%). ADVM quarterly D&A is now -50.22% below its all-time high of $1.79 million, reached on 30 September 2022.ADVM Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$3.85 M
-$619.00 K-13.84%
30 September 2024
Summary:
Adverum Biotechnologies TTM depreciation & amortization is currently $3.85 million, with the most recent change of -$619.00 thousand (-13.84%) on 30 September 2024. Over the past year, it has dropped by -$2.50 million (-39.31%). ADVM TTM D&A is now -42.46% below its all-time high of $6.70 million, reached on 31 March 2023.ADVM TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADVM Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.5% | -41.0% | -39.3% |
| 3 y3 years | +35.7% | -7.5% | -12.4% |
| 5 y5 years | +222.5% | +138.6% | +139.6% |
ADVM Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -13.5% | +35.7% | -50.2% | at low | -42.5% | at low |
| 5 y | 5 years | -13.5% | +258.8% | -50.2% | +151.4% | -42.5% | +144.9% |
| alltime | all time | -13.5% | >+9999.0% | -50.2% | >+9999.0% | -42.5% | >+9999.0% |
Adverum Biotechnologies Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $890.00 K(-6.9%) | $3.85 M(-13.8%) |
| June 2024 | - | $956.00 K(-4.1%) | $4.47 M(-11.4%) |
| Mar 2024 | - | $997.00 K(-1.2%) | $5.05 M(-10.5%) |
| Dec 2023 | $5.64 M(-13.5%) | $1.01 M(-33.1%) | $5.64 M(-11.1%) |
| Sept 2023 | - | $1.51 M(-1.6%) | $6.35 M(-4.2%) |
| June 2023 | - | $1.53 M(-3.6%) | $6.63 M(-1.0%) |
| Mar 2023 | - | $1.59 M(-7.0%) | $6.70 M(+2.6%) |
| Dec 2022 | $6.53 M(+40.5%) | $1.71 M(-4.3%) | $6.53 M(+6.4%) |
| Sept 2022 | - | $1.79 M(+11.5%) | $6.14 M(+15.5%) |
| June 2022 | - | $1.60 M(+12.5%) | $5.31 M(+8.3%) |
| Mar 2022 | - | $1.43 M(+7.8%) | $4.90 M(+5.6%) |
| Dec 2021 | $4.64 M(+11.7%) | $1.32 M(+37.4%) | $4.64 M(+5.6%) |
| Sept 2021 | - | $962.00 K(-19.5%) | $4.40 M(-4.8%) |
| June 2021 | - | $1.20 M(+2.5%) | $4.62 M(-2.2%) |
| Mar 2021 | - | $1.17 M(+8.3%) | $4.72 M(+13.6%) |
| Dec 2020 | $4.16 M(+164.3%) | $1.08 M(-9.1%) | $4.16 M(+21.0%) |
| Sept 2020 | - | $1.19 M(-8.6%) | $3.44 M(+31.0%) |
| June 2020 | - | $1.30 M(+116.5%) | $2.62 M(+50.2%) |
| Mar 2020 | - | $599.00 K(+69.2%) | $1.75 M(+11.0%) |
| Dec 2019 | $1.57 M(-10.1%) | $354.00 K(-5.1%) | $1.57 M(-2.2%) |
| Sept 2019 | - | $373.00 K(-11.2%) | $1.61 M(+7.4%) |
| June 2019 | - | $420.00 K(-1.4%) | $1.50 M(-12.8%) |
| Mar 2019 | - | $426.00 K(+9.5%) | $1.72 M(-1.9%) |
| Dec 2018 | $1.75 M | $389.00 K(+48.5%) | $1.75 M(-6.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $262.00 K(-59.1%) | $1.86 M(-12.8%) |
| June 2018 | - | $640.00 K(+39.4%) | $2.14 M(+4.9%) |
| Mar 2018 | - | $459.00 K(-8.9%) | $2.04 M(-2.7%) |
| Dec 2017 | $2.10 M(+30.8%) | $504.00 K(-6.0%) | $2.10 M(+0.8%) |
| Sept 2017 | - | $536.00 K(-0.7%) | $2.08 M(+4.2%) |
| June 2017 | - | $540.00 K(+4.7%) | $2.00 M(+11.0%) |
| Mar 2017 | - | $516.00 K(+6.0%) | $1.80 M(+12.2%) |
| Dec 2016 | $1.60 M(+97.4%) | $487.00 K(+7.5%) | $1.60 M(+12.7%) |
| Sept 2016 | - | $453.00 K(+32.1%) | $1.42 M(+17.5%) |
| June 2016 | - | $343.00 K(+7.2%) | $1.21 M(+19.3%) |
| Mar 2016 | - | $320.00 K(+4.6%) | $1.01 M(+24.9%) |
| Dec 2015 | $812.00 K(+401.2%) | $306.00 K(+27.0%) | $812.00 K(+38.8%) |
| Sept 2015 | - | $241.00 K(+63.9%) | $585.00 K(+48.9%) |
| June 2015 | - | $147.00 K(+24.6%) | $393.00 K(+45.0%) |
| Mar 2015 | - | $118.00 K(+49.4%) | $271.00 K(+67.3%) |
| Dec 2014 | $162.00 K(+523.1%) | $79.00 K(+61.2%) | $162.00 K(+78.0%) |
| Sept 2014 | - | $49.00 K(+96.0%) | $91.00 K(+85.7%) |
| June 2014 | - | $25.00 K(+177.8%) | $49.00 K(+58.1%) |
| Mar 2014 | - | $9000.00(+12.5%) | $31.00 K(+19.2%) |
| Dec 2013 | $26.00 K(+2500.0%) | $8000.00(+14.3%) | $26.00 K(+44.4%) |
| Sept 2013 | - | $7000.00(0.0%) | $18.00 K(+63.6%) |
| June 2013 | - | $7000.00(+75.0%) | $11.00 K(+175.0%) |
| Mar 2013 | - | $4000.00 | $4000.00 |
| Dec 2012 | $1000.00 | - | - |
FAQ
- What is Adverum Biotechnologies annual depreciation & amortization?
- What is the all time high annual D&A for Adverum Biotechnologies?
- What is Adverum Biotechnologies annual D&A year-on-year change?
- What is Adverum Biotechnologies quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Adverum Biotechnologies?
- What is Adverum Biotechnologies quarterly D&A year-on-year change?
- What is Adverum Biotechnologies TTM depreciation & amortization?
- What is the all time high TTM D&A for Adverum Biotechnologies?
- What is Adverum Biotechnologies TTM D&A year-on-year change?
What is Adverum Biotechnologies annual depreciation & amortization?
The current annual D&A of ADVM is $5.64 M
What is the all time high annual D&A for Adverum Biotechnologies?
Adverum Biotechnologies all-time high annual depreciation & amortization is $6.53 M
What is Adverum Biotechnologies annual D&A year-on-year change?
Over the past year, ADVM annual depreciation & amortization has changed by -$884.00 K (-13.54%)
What is Adverum Biotechnologies quarterly depreciation & amortization?
The current quarterly D&A of ADVM is $890.00 K
What is the all time high quarterly D&A for Adverum Biotechnologies?
Adverum Biotechnologies all-time high quarterly depreciation & amortization is $1.79 M
What is Adverum Biotechnologies quarterly D&A year-on-year change?
Over the past year, ADVM quarterly depreciation & amortization has changed by -$619.00 K (-41.02%)
What is Adverum Biotechnologies TTM depreciation & amortization?
The current TTM D&A of ADVM is $3.85 M
What is the all time high TTM D&A for Adverum Biotechnologies?
Adverum Biotechnologies all-time high TTM depreciation & amortization is $6.70 M
What is Adverum Biotechnologies TTM D&A year-on-year change?
Over the past year, ADVM TTM depreciation & amortization has changed by -$2.50 M (-39.31%)